Emvision Medical Devices Ltd (EMV) — Capital Reinvestment Ratio
Latest as of December 2022:
0.01x
Emvision Medical Devices Ltd (EMV) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (AU$2.92 Million) in capital expenditures (AU$20.23K). See how much free cash does Emvision Medical Devices Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
AU$2.92 Million
AUD
Capital Expenditures
AU$20.23K
AUD
Data as of
Dec 2022
Most recent filing
Emvision Medical Devices Ltd Capital Reinvestment Ratio (2023–2023)
This chart tracks Emvision Medical Devices Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Emvision Medical Devices Ltd (2023–2023)
Year-by-year Capital Reinvestment Ratio for Emvision Medical Devices Ltd from 2023 to 2023. For live market cap and broader valuation context, see EMV stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.22x | AU$834.15K | AU$187.29K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow